Factors Predicting Response to Progestin Treatment for Complex Atypical Hyperplasia/Well Differentiated Endometrial Carcinoma in Premenopausal Patients.

被引：0
|
作者：
Aoyama, C.
Penner, K.
Ostrzega, N.
Rao, J.
Walsh, C.
Dorigo, O.
Cass, I.
Balzer, B.
Holschneider, C.
机构：
[1] Olive View UCLA Med Ctr, Sylmar, CA USA
[2] UCLA Med Ctr, Los Angeles, CA USA
[3] Cedar Sinai Med Ctr, Los Angeles, CA USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
997
引用
收藏
页码：236A / 236A
页数：1
相关论文
共 50 条
  • [11] Effectiveness of megestrol for the treatment of patients with atypical endometrial hyperplasia or endometrial endometrioid adenocarcinoma (Stage IA, well differentiated)
    Akhavan, Setareh
    Sabet, Fahimeh
    Mousavi, Azam-Sadat
    Gilani, Mitra
    Hasani, Shahrzad
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2021, 10 (03) : 138 - 143
  • [12] EFFECTIVENESS OF MEGESTROL FOR THE TREATMENT OF PATIENTS WITH ATYPICAL ENDOMETRIAL HYPERPLASIA OR ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA (STAGE IA, WELL DIFFERENTIATED)
    Akhavan, Setareh
    Sabet, Fahimeh
    Mousavi, Azamsadat
    Hasani, Shahrzad Sheikh
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A165 - A166
  • [13] Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy
    Penner, Kristine R.
    Dorigo, Oliver
    Aoyama, Chisa
    Ostrzega, Nora
    Balzer, Bonnie L.
    Rao, Jianyu
    Walsh, Christine S.
    Cass, Ilana
    Holschneider, Christine H.
    GYNECOLOGIC ONCOLOGY, 2012, 124 (03) : 542 - 548
  • [14] EVALUATION OF CRITERIA FOR DISTINGUISHING ATYPICAL ENDOMETRIAL HYPERPLASIA FROM WELL-DIFFERENTIATED CARCINOMA
    KURMAN, RJ
    NORRIS, HJ
    CANCER, 1982, 49 (12) : 2547 - 2559
  • [15] Identifying predictors of response to progestin treatment of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in young women
    Penner, K. R.
    Cass, I.
    Walsh, C.
    Aoyama, C.
    Rao, J.
    Balzer, B.
    Dorigo, O.
    Holschneider, C. H.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S76 - S76
  • [16] Analysis of the endometrial stroma may play an important role in predicting progestin response in complex atypical hyperplasia or grade I adenocarcinoma
    Neal, A.
    Lai, T.
    Nunez, M.
    Lay, F. D.
    Morselli, M.
    Amneus, M. W.
    Zakhour, M.
    Moatamed, N.
    Memarzadeh, S.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 238 - 238
  • [17] Factors Predictive of Endometrial Carcinoma in Patients with Atypical Endometrial Hyperplasia on Preoperative Histology
    Touboul, Cyril
    Piel, Bruno
    Koskas, Martin
    Gonthier, Clementine
    Ballester, Marcos
    Cortez, Annie
    Darai, Emile
    ANTICANCER RESEARCH, 2014, 34 (10) : 5670 - 5676
  • [18] Preoperative Factors of Endometrial Carcinoma in Patients Undergoing Hysterectomy for Atypical Endometrial Hyperplasia
    Burrows, Adelaide
    Pudwell, Jessica
    Bougie, Olga
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2021, 43 (07) : 822 - 830
  • [19] FGFR2 isoform switching strongly associates with progestin treatment failure in atypical hyperplasia and well-differentiated endometrial cancer.
    Sengal, Asmerom
    Smith, Deborah
    Rogers, Rebecca
    Snell, Cameron
    Williams, Elizabeth
    Pollock, Pamela
    CLINICAL CANCER RESEARCH, 2021, 27 (03)
  • [20] Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium
    Yu, Mei
    Yang, Jia-xin
    Wu, Ming
    Lang, Jing-he
    Huo, Zhen
    Shen, Keng
    FERTILITY AND STERILITY, 2009, 92 (06) : 2122 - 2124
12345